Big Pharma’s pricing power still strong, New York gastroenterologist says 

Big Pharma, private equity and private payers are some of the forces Gabriel Ionescu, MD, sees as decision makers in the future of healthcare. 

Advertisement

Dr. Ionescu is a gastroenterologist at Wyckoff Heights Medical Center in New York City. He joined Becker’s ASC Review to discuss his predictions. 

Question: What major forces are deciding the future of healthcare?

Dr. Ionescu: Healthcare will be influenced by the government, especially for a sicker, older population. Private insurers will continue to diversify their business-acquiring practices and other services. 

Expansion will be good for hospitals. However, they will likely have to spend more on contract work, while private equity will continue private practice consolidation, especially in procedural specialties. Big Pharma will continue to exert pricing power, despite the rise in the discount outlets such as Mark Cuban’s company. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.